XMD16-5 is a TNK2 inhibitor. TNK2 genomic amplification has been associated with late-stage or metastatic lung and prostate Ys. Overexpression of TNK2 promoted metastasis in a mouse model of breast Y. TNK2 signaling is disrupted in breast, prostate and gastrointestinal tumors.
Molecular Weight:
416.48
Purity:
98.53%
CAS Number:
[1345098-78-3]
Formula:
C23H24N6O2
Target:
Tyrosinase|||PPAR
T3710
* VAT and and shipping costs not included. Errors and price changes excepted